フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Amgen (Nasdaq: AMGN) and Abgenix, Inc. (Nasdaq: ABGX) today announced that Amgen has completed the Biologic License Application (BLA) submission...
FREMONT, Calif., March 29 /PRNewswire-FirstCall/ -- At a special meeting held today, stockholders of Abgenix, Inc. (NASDAQ:ABGX) overwhelmingly...
FREMONT, Calif., Feb. 14 /PRNewswire-FirstCall/ -- Abgenix, Inc. (NASDAQ:ABGX) will announce financial results for the fourth quarter and full...
FREMONT, Calif., Jan. 5 /PRNewswire-FirstCall/ -- Abgenix, Inc. (NASDAQ:ABGX) will present at the 24th Annual JPMorgan Healthcare Conference on...
Provides Amgen With Full Ownership of Panitumumab and Eliminates a Denosumab Royalty THOUSAND OAKS, Calif. and FREMONT, Calif., Dec. 14...
FREMONT, Calif., Nov. 9 /PRNewswire-FirstCall/ -- Abgenix, Inc. (NASDAQ:ABGX) announced today the appointment of Jeffrey H. Knapp to the newly...
First EGFr Inhibitor to Demonstrate Improvement in Progression-Free Survival as Monotherapy for Metastatic Colorectal Cancer THOUSAND OAKS...
First EGFr Inhibitor to Demonstrate Improvement in Progression-Free Survival as Monotherapy for Metastatic Colorectal Cancer ? Amgen...
Amgen (Nasdaq:AMGN) and Abgenix, Inc. (Nasdaq:ABGX) will host a joint conference call on November 3 at 8:00 a.m. Pacific Time to discuss the...
FREMONT, Calif., Oct. 25 /PRNewswire-FirstCall/ -- Abgenix, Inc. (NASDAQ:ABGX) today announced financial results for the third quarter ended...
FREMONT, Calif., Oct. 18 /PRNewswire-FirstCall/ -- Abgenix, Inc. (NASDAQ:ABGX) will announce third quarter financial results on Tuesday, October...
FREMONT, Calif., Sept. 1 /PRNewswire-FirstCall/ -- Abgenix, Inc. (NASDAQ:ABGX) today announced that it has been invited to present at three...
Abgenix and Amgen Announce FDA Grants Panitumumab Fast Track Designation for Metastatic Colorectal Cancer THOUSAND OAKS, Calif. and FREMONT...
Abgenix Announces Second Quarter 2005 Financial Results Strategic Review Results in Special Charges FREMONT, Calif., July 26...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約